Founded in 1996, Optonol specializes in ophthalmologic devices and surgical implants for glaucoma treatment. Their flagship product, Ex-Press, is a miniature surgical implant used to lower intra-ocular pressure in glaucoma patients. Optonol's expertise and multidisciplinary approach have positioned them as a leader in the field, with the potential to become the gold standard in glaucoma surgery.